Cargando…
Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathway
Ro52/Trim21 is targeted as an autoantigen in systemic lupus erythematosus and Sjögren's syndrome. Polymorphisms in the Ro52 gene have been linked to these autoimmune conditions, but the molecular mechanism by which Ro52 may promote development of systemic autoimmune diseases has not been explor...
Autores principales: | Espinosa, Alexander, Dardalhon, Valerie, Brauner, Susanna, Ambrosi, Aurelie, Higgs, Rowan, Quintana, Fransisco J., Sjöstrand, Maria, Eloranta, Maija-Leena, Ní Gabhann, Joan, Winqvist, Ola, Sundelin, Birgitta, Jefferies, Caroline A., Rozell, Björn, Kuchroo, Vijay K., Wahren-Herlenius, Marie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722164/ https://www.ncbi.nlm.nih.gov/pubmed/19635858 http://dx.doi.org/10.1084/jem.20090585 |
Ejemplares similares
-
Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block
por: Salomonsson, Stina, et al.
Publicado: (2005) -
Self Protection from Anti-Viral Responses – Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors
por: Higgs, Rowan, et al.
Publicado: (2010) -
Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus
por: Yoshimi, Ryusuke, et al.
Publicado: (2012) -
Epigenetic Disregulation in Oral Cancer
por: Mascolo, Massimo, et al.
Publicado: (2012) -
Biofeedback and the behavioral treatment of disorders of disregulation.
por: Schwartz, G. E.
Publicado: (1979)